tyrosine kinase inhibitor
midostaurin
venetoclax
thioguanine
ponatinib
olutasidenib
roscovitine
ivosidenib
idelalisib
antileukemic
chloraminophene
omacetaxine
ruxolitinib
antileukemia
asciminib
myeloleukemia
vosaroxin
talacotuzumab
carfilzomib
pacritinib
pomalidomide
lenalidomide
melphalan flufenamide
leukemic
homoharringtonine
tafasitamab
isatuximab
clofarabine
pegaspargase
506U78
promyeloleukemia
ubenimex
myeloleukemic
preleukemia
chemo
cytarabine
chemodrug
atiprimod
Alkeran
picoplatin
antileprotic
leukemogenicity
melphalan
chronic leukemia
trilaciclib
acute lymphoblastic leukemia
belantamab mafodotin
cytotoxic drug
chemicotherapeutic
dacarbazine